HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,471 | +57.6% | 14,050 | +77.4% | 0.00% | – |
| Q2 2023 | $9,185 | +70553.8% | 7,918 | -1.6% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 8,048 | +67.4% | 0.00% | – |
| Q4 2022 | $12 | -100.0% | 4,809 | -93.2% | 0.00% | -100.0% |
| Q3 2022 | $301,000 | +178.7% | 71,170 | +84.3% | 0.01% | +150.0% |
| Q2 2022 | $108,000 | -30.3% | 38,620 | +43.0% | 0.00% | +100.0% |
| Q1 2022 | $155,000 | -35.1% | 26,999 | +3.1% | 0.00% | -75.0% |
| Q4 2021 | $239,000 | -51.4% | 26,186 | -43.1% | 0.00% | -69.2% |
| Q3 2021 | $492,000 | +693.5% | 45,993 | +1054.2% | 0.01% | +550.0% |
| Q2 2021 | $62,000 | -83.1% | 3,985 | -82.4% | 0.00% | -66.7% |
| Q1 2021 | $367,000 | +697.8% | 22,619 | +929.5% | 0.01% | +500.0% |
| Q4 2020 | $46,000 | -32.4% | 2,197 | -52.2% | 0.00% | 0.0% |
| Q3 2020 | $68,000 | -53.4% | 4,598 | -53.4% | 0.00% | -83.3% |
| Q2 2020 | $146,000 | +35.2% | 9,867 | +114.8% | 0.01% | -33.3% |
| Q4 2019 | $108,000 | +8.0% | 4,593 | -15.3% | 0.01% | +28.6% |
| Q3 2019 | $100,000 | +9900.0% | 5,423 | +13457.5% | 0.01% | – |
| Q4 2018 | $1,000 | -87.5% | 40 | -85.1% | 0.00% | -100.0% |
| Q3 2018 | $8,000 | -94.7% | 268 | -93.1% | 0.00% | -88.9% |
| Q2 2018 | $152,000 | -5.0% | 3,902 | -33.0% | 0.01% | -35.7% |
| Q1 2018 | $160,000 | +7900.0% | 5,826 | +5668.3% | 0.01% | – |
| Q4 2017 | $2,000 | -97.8% | 101 | -98.2% | 0.00% | -100.0% |
| Q3 2017 | $89,000 | – | 5,504 | – | 0.01% | – |
| Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2017 | $3,000 | +200.0% | 200 | +150.0% | 0.00% | – |
| Q4 2016 | $1,000 | -83.3% | 80 | -76.6% | 0.00% | -100.0% |
| Q3 2016 | $6,000 | -75.0% | 342 | -74.6% | 0.00% | -50.0% |
| Q2 2016 | $24,000 | +166.7% | 1,344 | +168.8% | 0.00% | +100.0% |
| Q1 2016 | $9,000 | +800.0% | 500 | +843.4% | 0.00% | – |
| Q4 2015 | $1,000 | -96.3% | 53 | -94.0% | 0.00% | -100.0% |
| Q2 2015 | $27,000 | -6.9% | 880 | -56.3% | 0.00% | -50.0% |
| Q1 2015 | $29,000 | +81.2% | 2,016 | +25.2% | 0.00% | +100.0% |
| Q4 2014 | $16,000 | – | 1,610 | +8844.4% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 18 | -99.7% | 0.00% | -100.0% |
| Q2 2014 | $64,000 | +300.0% | 5,151 | +358.7% | 0.01% | +300.0% |
| Q1 2014 | $16,000 | – | 1,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |